# Donegal Group Inc: financial statements, quarterly

DGICA · Nasdaq · CIK 800457 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dgica.md) · [Financials](/companies/dgica/financials.md) · [Filings](/companies/dgica/filings.md) · [Insiders](/companies/dgica/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dgica/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [234](/filings/0001140361-24-045419.md) | [239 d](/filings/0001140361-26-008268.md) | [241](/filings/0001140361-25-017502.md) | [247](/filings/0001140361-25-028779.md) | [252](/filings/0001140361-25-040238.md) | [250 d](/filings/0001140361-26-008268.md) | [245](/filings/0001140361-26-019516.md) | [247](/filings/0001140361-26-031159.md) | [246](/filings/0001140361-25-040238.md) | [240 d](/filings/0001140361-26-008268.md) | [236](/filings/0001140361-26-019516.md) | [241](/filings/0001140361-26-031159.md) |
| Interest expense | $m | [0.2](/filings/0001140361-24-045419.md) | [0.2 d](/filings/0001140361-26-008268.md) | [0.2](/filings/0001140361-25-017502.md) | [0.2](/filings/0001140361-25-028779.md) | [0.4](/filings/0001140361-25-040238.md) | [0.3 d](/filings/0001140361-26-008268.md) | [0.3](/filings/0001140361-26-019516.md) | [0.3](/filings/0001140361-26-031159.md) | [0.3](/filings/0001140361-25-040238.md) | [0.3 d](/filings/0001140361-26-008268.md) | [0.3](/filings/0001140361-26-019516.md) | [0.3](/filings/0001140361-26-031159.md) |
| Income tax | $m | [(0.2)](/filings/0001140361-24-045419.md) | [(0.5) d](/filings/0001140361-26-008268.md) | [1.3](/filings/0001140361-25-017502.md) | [0.9](/filings/0001140361-25-028779.md) | [3.7](/filings/0001140361-25-040238.md) | [5.7 d](/filings/0001140361-26-008268.md) | [6.0](/filings/0001140361-26-019516.md) | [3.6](/filings/0001140361-26-031159.md) | [5.0](/filings/0001140361-25-040238.md) | [3.8 d](/filings/0001140361-26-008268.md) | [2.6](/filings/0001140361-26-019516.md) | [5.2](/filings/0001140361-26-031159.md) |
| Net income | $m | [(0.8)](/filings/0001140361-24-045419.md) | [(2.0) d](/filings/0001140361-26-008268.md) | [6.0](/filings/0001140361-25-040238.md) | [4.2](/filings/0001140361-25-040238.md) | [16.8](/filings/0001140361-25-040238.md) | [24.0 d](/filings/0001140361-26-008268.md) | [25.2](/filings/0001140361-26-031159.md) | [16.9](/filings/0001140361-26-031159.md) | [20.1](/filings/0001140361-25-040238.md) | [17.2 d](/filings/0001140361-26-008268.md) | [11.5](/filings/0001140361-26-031159.md) | [22.3](/filings/0001140361-26-031159.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [23.7](/filings/0001140361-23-051347.md) | [23.8](/filings/0001140361-25-007891.md) | [19.8](/filings/0001140361-24-024270.md) | [24.2](/filings/0001140361-24-036147.md) | [28.7](/filings/0001140361-24-045419.md) | [52.9](/filings/0001140361-26-008268.md) | [64.3](/filings/0001140361-25-017502.md) | [57.4](/filings/0001140361-25-028779.md) | [38.6](/filings/0001140361-25-040238.md) | [26.8](/filings/0001140361-26-031159.md) | [35.5](/filings/0001140361-26-019516.md) | [23.7](/filings/0001140361-26-031159.md) |
| Total assets | $m | [2,260](/filings/0001140361-23-051347.md) | [2,266](/filings/0001140361-25-007891.md) | [2,294](/filings/0001140361-24-024270.md) | [2,335](/filings/0001140361-24-036147.md) | [2,346](/filings/0001140361-24-045419.md) | [2,336](/filings/0001140361-26-008268.md) | [2,368](/filings/0001140361-25-017502.md) | [2,408](/filings/0001140361-25-028779.md) | [2,422](/filings/0001140361-25-040238.md) | [2,387](/filings/0001140361-26-031159.md) | [2,449](/filings/0001140361-26-019516.md) | [2,482](/filings/0001140361-26-031159.md) |
| Total liabilities | $m | [1,787](/filings/0001140361-23-051347.md) | [1,787](/filings/0001140361-25-007891.md) | [1,809](/filings/0001140361-24-024270.md) | [1,851](/filings/0001140361-24-036147.md) | [1,833](/filings/0001140361-24-045419.md) | [1,790](/filings/0001140361-26-008268.md) | [1,784](/filings/0001140361-25-017502.md) | [1,802](/filings/0001140361-25-028779.md) | [1,794](/filings/0001140361-25-040238.md) | [1,746](/filings/0001140361-26-031159.md) | [1,800](/filings/0001140361-26-019516.md) | [1,816](/filings/0001140361-26-031159.md) |
| Shareholders' equity | $m | [473](/filings/0001140361-24-045419.md) | [480](/filings/0001140361-26-008268.md) | [485](/filings/0001140361-25-040238.md) | [484](/filings/0001140361-25-040238.md) | [513](/filings/0001140361-25-040238.md) | [546](/filings/0001140361-26-031159.md) | [585](/filings/0001140361-26-031159.md) | [606](/filings/0001140361-26-031159.md) | [627](/filings/0001140361-25-040238.md) | [640](/filings/0001140361-26-031159.md) | [649](/filings/0001140361-26-031159.md) | [666](/filings/0001140361-26-031159.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [13.0 d](/filings/0001140361-24-045419.md) | [2.6 d](/filings/0001140361-26-008268.md) | [4.8](/filings/0001140361-25-017502.md) | [21.7 d](/filings/0001140361-25-028779.md) | [12.7 d](/filings/0001140361-25-040238.md) | [28.2 d](/filings/0001140361-26-008268.md) | [25.7](/filings/0001140361-26-019516.md) | [12.1 d](/filings/0001140361-26-031159.md) | [22.4 d](/filings/0001140361-25-040238.md) | [10.0 d](/filings/0001140361-26-008268.md) | [20.2](/filings/0001140361-26-019516.md) | [5.9 d](/filings/0001140361-26-031159.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [5.5 d](/filings/0001140361-23-051347.md) | [5.6 d](/filings/0001140361-24-011762.md) | [5.6](/filings/0001140361-25-017502.md) | [5.7 d](/filings/0001140361-25-028779.md) | [5.7 d](/filings/0001140361-25-040238.md) | [5.8 d](/filings/0001140361-26-008268.md) | [6.0](/filings/0001140361-26-019516.md) | [6.5 d](/filings/0001140361-26-031159.md) | [6.6 d](/filings/0001140361-25-040238.md) | [6.6 d](/filings/0001140361-26-008268.md) | [6.7](/filings/0001140361-26-019516.md) | [7.0 d](/filings/0001140361-26-031159.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: not reported

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.